Related Experiment Video
Updated: Jul 16, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
AngioVac-assisted management of histoplasma capsulatum endocarditis in a bioprosthetic aortic valve: challenges and
Qutaiba Qafisheh1, Abdalhakim Shubietah2, Roaa Aljunaidi3
1Department of Internal Medicine, University of Toledo, Toledo, USA.
Background:
Histoplasma capsulatum infective endocarditis (IE) is rare and often fatal, especially in prosthetic valve patients, due to delayed diagnosis and limited therapeutic options. This case demonstrates the utility of AngioVac for managing large fungal vegetations, underscores the importance of considering fungal IE in culture-negative cases, and highlights the role of a multidisciplinary approach in high-risk patients. We report a 76-year-old female with a bioprosthetic aortic valve who presented with persistent culture-negative fever, splenic infarcts, and large vegetations on her prosthetic valve. Extensive diagnostic workup confirmed fungal endocarditis after AngioVac-assisted debulking revealed H. capsulatum on tissue cultures. Despite prompt initiation of antifungal therapy and multidisciplinary management, her course was complicated by recurrent embolic events, septic shock, and eventual death.
Conclusion:
This case underscores the importance of considering fungal IE in culture-negative cases, especially in high-risk patients such as those with prosthetic valves. It also highlights the role of advanced diagnostic techniques and minimally invasive interventions like AngioVac in managing complex cases, despite their limitations.
Insights
Histoplasma capsulatum infective endocarditis (IE) is rare. AngioVac aided in managing large fungal vegetations in a prosthetic valve patient, highlighting the need for considering fungal IE in culture-negative cases.
Area of Science:
- Infectious Diseases
- Cardiology
- Medical Device Technology
Background:
- Histoplasma capsulatum infective endocarditis (IE) is a rare but often fatal condition.
- Prosthetic valve patients are at high risk due to diagnostic delays and limited treatment options.
- Fungal IE should be considered in culture-negative cases, particularly in high-risk individuals.
Purpose of the Study:
- To report a case of Histoplasma capsulatum infective endocarditis in a prosthetic valve patient.
- To demonstrate the utility of the AngioVac system for managing large fungal vegetations.
- To emphasize the importance of a multidisciplinary approach in managing complex IE cases.
Main Methods:
- A 76-year-old female with a bioprosthetic aortic valve presented with persistent culture-negative fever and splenic infarcts.
- AngioVac-assisted debulking was performed for large vegetations on the prosthetic valve.
- Tissue cultures obtained during debulking confirmed Histoplasma capsulatum.
Main Results:
- AngioVac facilitated the removal of large fungal vegetations, enabling diagnosis of Histoplasma capsulatum.
- Despite prompt antifungal therapy and multidisciplinary management, the patient experienced recurrent embolic events and septic shock.
- The patient ultimately succumbed to the infection.
Conclusions:
- This case highlights the critical need to consider fungal IE in culture-negative endocarditis, especially in patients with prosthetic valves.
- Advanced diagnostic tools and minimally invasive interventions like AngioVac can play a role in managing complex fungal IE.
- Despite interventions, the management of severe fungal IE remains challenging, underscoring the need for early diagnosis and comprehensive care.
More Related Videos
07:50An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management